<DOC>
	<DOCNO>NCT01248273</DOCNO>
	<brief_summary>The purpose study 1 ) test safety vaccine find effect , good and/or bad , , 2 ) find vaccine stimulates immune system . The vaccine study contain several part . The first part call antigen . These antigens `` fingerprint '' find many cancer cell , especially ovary , fallopian tube , peritoneal cavity ( inside line abdomen ) The purpose study see investigator help immune system recognize cancer cell normal remove .</brief_summary>
	<brief_title>Unimolecular Pentavalent ( Globo-H-GM2-sTn-TF-Tn ) Immunization Patients With Epithelial Ovarian , Fallopian Tube , Peritoneal Cancer First Remission</brief_title>
	<detailed_description />
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Adjuvants , Immunologic</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Any histologically document stage III IV epithelial carcinoma arise ovary , fallopian tube peritoneum . History cytoreductive surgery chemotherapy least one platinumbased chemotherapy regimen part primary treatment . Patients must first complete clinical remission . Complete clinical remission define serum CA125 within institutional normal limit , negative physical examination , definite evidence disease compute tomography ( CT ) abdomen pelvis . Lymph node and/or soft tissue abnormality ≤ 1.0cm often present pelvis consider definite evidence disease . Eligibility determine anatomical imaging ( ie . MRI CT ) . Positive PET image ( perform ) exclude patient criterion meet anatomical imaging negative . Adequate organ function define Bone marrow function : Absolute neutrophil count ( ANC ) great equal 1,000/mm³ , grade 1 . Platelets great equal 100,000/mm³ . Renal function : Serum creatinine less equal 1.5 x institutional upper limit normal ( ULN ) , CTCAE v4.0 grade 1 . Hepatic function : Bilirubin , SGOT , alkaline phosphatase less equal 2.5 x ULN Negative stool hemoccult ( negative endoscopic evaluation positive ) . External hemorrhoid common source positive hemoccult exclude patient . TSH elevate normal range KPS &gt; = 80 % . Patients sign informed consent document sign authorization permitting release personal health information . Age &gt; 18 year Patients must recover clinically significant side effect prior chemotherapy Pregnant nursing woman Patients invasive malignancy ( ) evidence cancer present within last 5 year , whose previous cancer treatment contraindicate protocol therapy exclude . Nonmelanoma skin cancer exception exclude patient . Patients history seafood allergy . Patients previously receive vaccine antigens current trial . Patients history immunodeficiency autoimmune disease ( exclude treat hypothyroidism ) . Patients active CNS tumor .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GLOBO H-KLH CONJUGATE</keyword>
	<keyword>MUC-1 KLH</keyword>
	<keyword>QS-21</keyword>
	<keyword>TF ( C ) -KLH</keyword>
	<keyword>TN ( C ) -KLH</keyword>
	<keyword>Immunization</keyword>
	<keyword>Vaccine</keyword>
	<keyword>09-184</keyword>
</DOC>